Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

| DelveInsight The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such as Debio 4126 (Debiopharm International SA), ALXN2420 ...

Introduction The management of active patients with symptomatic knee osteoarthritis (KnOA) who are too young for total knee arthroplasty poses a specific challenge to clinicians. Research studies show ...

Table 01: Global Growth Hormone Deficiency Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034 Table 02: Global Growth Hormone Deficiency Market Size (US$ Bn) Forecast, by Disease Indication, ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.